These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38225986)

  • 21. Assessment of remifentanil for rapid sequence induction and intubation in patients at risk of pulmonary aspiration of gastric contents compared to rapid-onset paralytic agents: study protocol for a non-inferiority simple blind randomized controlled trial (the REMICRUSH study).
    Grillot N; Garot M; Lasocki S; Huet O; Bouzat P; Le Moal C; Oudot M; Chatel-Josse N; El Amine Y; Danguy des Déserts M; Bruneau N; Cinotti R; David JS; Langeron O; Minville V; Tching-Sin M; Faurel-Paul E; Lerebourg C; Flattres-Duchaussoy D; Jobert A; Asehnoune K; Feuillet F; Roquilly A
    Trials; 2021 Mar; 22(1):237. PubMed ID: 33785069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retained Gastric Contents After Adequate Fasting Associated with GLP-1 Receptor Agonist Use: A Report of 3 Cases.
    Kittner SL; Talbott AL; Vishneski SR; Narbaiza J; Shields JS
    JBJS Case Connect; 2023 Oct; 13(4):. PubMed ID: 37943967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetic of paracetamol and atorvastatin with co-administration of semaglutide.
    Langeskov EK; Kristensen K
    Pharmacol Res Perspect; 2022 Aug; 10(4):e00962. PubMed ID: 35799471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sgemaglutide in type 2 diabetes - is it the best glucagon-like peptide 1 receptor agonist (GLP-1R agonist)?
    Doggrell SA
    Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):371-377. PubMed ID: 29439603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinically significant emesis in a patient taking a long-acting GLP-1 receptor agonist for weight loss.
    Weber M; Siddarthan I; Mack PF
    Br J Anaesth; 2023 Aug; 131(2):e37-e39. PubMed ID: 37302962
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention of pulmonary gastric contents aspiration.].
    Moro ET
    Rev Bras Anestesiol; 2004 Apr; 54(2):261-75. PubMed ID: 19471734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative starvation and pulmonary aspiration. New perspectives and guidelines.
    Scarlett M; Crawford-Sykes A; Nelson M
    West Indian Med J; 2002 Dec; 51(4):241-5. PubMed ID: 12632641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms.
    Imeryüz N; Yeğen BC; Bozkurt A; Coşkun T; Villanueva-Peñacarrillo ML; Ulusoy NB
    Am J Physiol; 1997 Oct; 273(4):G920-7. PubMed ID: 9357836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity.
    Friedrichsen M; Breitschaft A; Tadayon S; Wizert A; Skovgaard D
    Diabetes Obes Metab; 2021 Mar; 23(3):754-762. PubMed ID: 33269530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasound assessment of the gastric contents for the guidance of the anaesthetic strategy in infants with hypertrophic pyloric stenosis: a prospective cohort study.
    Gagey AC; de Queiroz Siqueira M; Desgranges FP; Combet S; Naulin C; Chassard D; Bouvet L
    Br J Anaesth; 2016 May; 116(5):649-54. PubMed ID: 27106968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of regurgitation and pulmonary aspiration in a patient after gastric banding.
    Thekkethodika A
    Case Rep Anesthesiol; 2012; 2012():186104. PubMed ID: 22606403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship Between Oral Semaglutide Tablet Erosion and Pharmacokinetics: A Pharmacoscintigraphic Study.
    Baekdal TA; Donsmark M; Hartoft-Nielsen ML; Søndergaard FL; Connor A
    Clin Pharmacol Drug Dev; 2021 May; 10(5):453-462. PubMed ID: 33750044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and Clinical Implications of Semaglutide: A New Glucagon-Like Peptide (GLP)-1 Receptor Agonist.
    Hall S; Isaacs D; Clements JN
    Clin Pharmacokinet; 2018 Dec; 57(12):1529-1538. PubMed ID: 29915923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Various Dosing Schedules on the Pharmacokinetics of Oral Semaglutide: A Randomised Trial in Healthy Subjects.
    van Hout M; Forte P; Jensen TB; Boschini C; Bækdal TA
    Clin Pharmacokinet; 2023 Apr; 62(4):635-644. PubMed ID: 36932262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute Pancreatitis in a Patient Taking Semaglutide.
    Patel F; Gan A; Chang K; Vega KJ
    Cureus; 2023 Aug; 15(8):e43773. PubMed ID: 37731423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes considered for injectable GLP-1 receptor agonist therapy or currently on insulin therapy.
    Wright EE; Aroda VR
    Postgrad Med; 2020 Nov; 132(sup2):26-36. PubMed ID: 32815423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid Evaluation of Gastric Content With Ultrasound: An Educational Tool.
    Nguyen H; Paluska MR; Falcon R; Petersen TR; Soneru C
    Cureus; 2023 Nov; 15(11):e49031. PubMed ID: 38024067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastric content and perioperative pulmonary aspiration in patients with diabetes mellitus: a scoping review.
    Xiao MZX; Englesakis M; Perlas A
    Br J Anaesth; 2021 Aug; 127(2):224-235. PubMed ID: 34023055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral semaglutide, first oral GLP-1 receptor agonist (Rybelsus®)].
    Paquot N
    Rev Med Liege; 2021 Dec; 76(12):896-903. PubMed ID: 34881835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral Semaglutide: A Review of the First Oral Glucagon-Like Peptide 1 Receptor Agonist.
    Bucheit JD; Pamulapati LG; Carter N; Malloy K; Dixon DL; Sisson EM
    Diabetes Technol Ther; 2020 Jan; 22(1):10-18. PubMed ID: 31436480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.